Indefinite Delivery Contract 75N91019D00037

The National Cancer Institute (NCI), a civilian agency within the U.S. Department of Health and Human Services, has awarded a multiple-award Indefinite Delivery/Indefinite Quantity (IDIQ) contract to acquire Genome Characterization Center (GCC) services. The contract, valued at up to $149,974,285, has a period of performance through January 2030. The GCC services include large-scale, high-resolution, and comprehensive sequencing and array platforms, such as whole exome sequencing, to support...

The National Cancer Institute (NCI) has awarded an Indefinite Delivery/Indefinite Quantity (IDIQ) contract, valued up to $149,974,285, to the University of North Carolina at Chapel Hill (UNC-CH) to provide Genome Characterization Center (GCC) services. The contract aims to acquire comprehensive genome sequencing and analysis capabilities to support NCI's cancer genomics research programs. The GCC services include whole exome sequencing, transcriptomics, and epigenomic characterization of...

This indefinite delivery contract (IDC) was awarded by the National Cancer Institute (NCI), a civilian federal agency, to Infinity Biologix LLC, doing business as Sampled Division, to acquire genome characterization center (GCC) services consisting of large-scale, high-resolution, and comprehensive sequencing and array platforms, including whole exome sequencing. The contract has a ceiling value of $149,974,285 and a period of performance through January 2030. The contract aims to support...

The federal contract IDV award is for Genome Characterization Center (GCC) services consisting of large-scale, high-resolution, and comprehensive sequencing and array platforms to support the National Cancer Institute's (NCI) Center for Cancer Genomics (CCG) program. The $149,974,285 multiple-award IDIQ contract was awarded to the New York Genome Center, Inc. (NYGC), a non-profit academic research institution, with a period of performance running through January 2030. The GCC services will...

The Environmental Protection Agency Office of Research and Development awarded an indefinite delivery contract to Biospyder Technologies, Inc. to provide targeted RNA sequencing analyses. The contract includes a potential value of $9.5 million over five years to evaluate treatment-related changes in gene expression from animal and plant samples. Three firm fixed price delivery orders have been issued against the contract. The first calls for analyses of 97 to 5,000 RNA samples at $123,951 to...

This Indefinite Delivery Contract (IDC) was awarded by the National Cancer Institute (NCI), a civilian agency of the U.S. Department of Health and Human Services, to The Washington University's Office of Sponsored Research Services Division. The contract is for Genome Characterization Center (GCC) services, which involve large-scale, high-resolution, and comprehensive sequencing and array platforms, including whole exome sequencing. The purpose is to perform genomic characterization of cancer...

The National Heart, Lung and Blood Institute, part of the National Institutes of Health and Department of Health and Human Services, awarded a single award Indefinite Delivery Contract to New York Genome Center, Inc. doing business as Nygc. The potential value of the contract is $500 million to be ordered through September 2033. A firm fixed price delivery order for $742,360 was also awarded for RNA-Seq services to support the Trans-Omics for Precision Medicine initiative's Centralized Omics...

The Department of the Interior's United States Geological Survey awarded a blanket purchase agreement to Novogene Corporation Inc. to provide microbial DNA and microRNA library preparation and next generation sequencing services. The single award BPA has a potential value of $120,000 and a period of performance from February 2022 through January 2027. Against this BPA, the agency has issued three firm fixed price calls valued at $16,060, $24,354, and $22,664 respectively, for preparing the...

Genedx, LLC was awarded a single-award indefinite delivery contract by the Department of Health and Human Services' National Institutes of Health Clinical Center to provide mutation analysis services with a potential value of $1,012,384.00 and a period of performance through June 2024. Under this contract and associated task orders, Genedx will deliver specialized genetic and genomic testing services from its Maryland laboratory to support the NIH Clinical Center's clinical research mission....

This Blanket Purchase Agreement between the United States Department of Agriculture Agricultural Research Service and Cornell University establishes a single award IDV to procure DNA and RNA sequencing services. The potential value of the agreement is $700,000 with an ordering period through August 2023. Task orders issued against the BPA include next generation sequencing, library preparation, and genomics services. Orders have been placed for Illumina sequencing runs, RNA sample library...